MicroRNA and Male Infertility: A Potential for Diagnosis

Headnote

Abstract

MicroRNAs (miRNAs) are small non-coding single stranded RNA molecules that are physiologically produced in eukaryotic cells to regulate or mostly down-regulate genes by pairing with their complementary base-sequence in related mRNA molecules in the cytoplasm. It has been reported that other than its function in many physiological cell processes, dysregulation of miRNAs plays a role in the development of many diseases. In this short review, the association between miRNAs and some male reproductive disorders is surveyed. Male factor Infertility is a devastating problem from which a notable percentage of couples suffer. However, the molecular mechanism of many infertility disorders has not been clearly elucidated. Since miRNAs have an important role in numerous biological cell processes and cellular dysfunctions, it is of interest to review the related literature on the role of miRNAs in the male reproductive organs. Aberrant expression of specific miRNAs is associated with certain male reproductive dysfunctions. For this reason, assessment of expression of such miRNAs may serve as a suitable molecular biomarker for diagnosis of those male infertility disorders. The presence of a single nucleotide polymorphism (SNP) at the miRNAs' binding site in its targeted mRNA has been reported to have an association with idiopathic male infertility. Also, a relation with male infertility has been shown with SNP in the genes of the factors necessary for miRNA biogenesis. Therefore, focusing on the role of miRNAs in male reproductive disorders can further elucidate the molecular mechanisms of male infertility and generate the potential for locating efficient biomarkers and therapeutic agents for these disorders.

Keywords: miRNA, Spermatogenesis, Male Infertility, Biomarker, Single Nucleotide Polymorphism

Citation: Khazaie Y, Nasr Esfahani MH. MicroRNA and male infertility: a potential for diagnosis. Int J Fertil Steril. 2014; 8(2): 113-118.

Introduction

MicroRNAs (miRNAs) are small non-coding single stranded RNA molecules of approximately 22 nucleotides that are physiologically produced in eukaryotic cells (1). After being expressed in the nucleus, miRNA plays a role in regulation of gene expression by pairing with its complementary base-sequence of the targeted mRNA molecule in the cytoplasm. This usually leads to gene silencing through degradation of targeted mRNA or interference with its translation (2, 3). After discovery of miRNAs, as single-stranded non-protein-coding regulatory RNA molecules in C. elegans by Lee et al. (4) in 1993, over 1500 miRNAs have currently been reported to be encoded by the human genome (5-7) which may target around 60% of mammalian genes in various human cell types (8). Figure 1 schematically depicts miRNA biogenesis.

Aside from the physiological regulation of gene expression in multiple biological processes such as cell cycle control and differentiation (9), cell growth and apoptosis (10) and embryo development (11), the role of miRNAs in development of many human diseases has been studied and reported. Mutation, dysfunction of biogenesis and dysregulation of miRNAs and their targets may lead to various diseases such as cardiovascular diseases (12), cancers (13), schizophrenia (14), renal function disorders (15), psoriasis (16), muscular disorders (17) and diabetes (18). A comprehensive database of whole miRNA-disease association, miRNA disease spectrum width (DSW), miRNA conservation and miRNA function has been published online at: http://202.38.126.151/hmdd/mirna/ md/, entitled "The Human microRNA Disease Database". Among diseases, we have chosen to focus on male infertility with the intent to conduct a literature review of the role of miRNAs in this field.

Infertility is a problem in 10-15% of couples worldwide (19). Approximately, 50% of the infertility cases are attributed to male factors and 60-5% of these cases are idiopathic (20). Of note, the molecular mechanisms of many male infertility disorders are not clear (20). The aim of this review is to pursue the relation between miRNAs and male infertility.

miRNA and spermatogenesis

The presence of miRNA in testis has been verified a few years ago (21). Later, researchers focused on finding the function of miRNAs in germinal tract physiology. Table 1 shows a brief description of the chronological order of discoveries related to miRNAs in testis molecular physiology [for additional information please refer to Papaioannou and Nef (22)].

Potential of extracellular miRNAs as biomarkers for infertility

In addition to the presence of miRNA at the cellular level, miRNAs have also been reported to be present in extracellular fluids such as plasma (34), saliva (35, 36), vaginal secretions, menstrual blood and semen (36). Aberrant expression of extracellular miRNA is attributed to different disorders (37). Altered expression of miRNAs, as with altered expression of some testis-specific mRNAs (38-41) has been recently reported in male infertility disorders, hence the possibility of locating potential miRNA biomarkers in male infertility has been proposed.

The first report of an alteration of miRNA expression in the testis of patients with non-obstructive azoospermia (NOA) has been reported by Lian et al. (42). Of note, that NOA which has a testis-origin, presents a diverse range of defects from hypospermatogenesis and sperm maturation arrest to Sertoli-cell-only-syndrome. Hence, assessment of differential expressions of miRNAs in these infertile individuals is a prerequisite.

Wang et al. (43) examined pooled semen samples obtained from infertile men and compared the results with normal fertile individuals as controls. They found alterations in miRNA profiles by Solexa Sequencing (a sequencing method based on reversible dye-terminators technology and engineered polymerases) in both azoospermia and asthenozoospermia. These authors considered a cut of value of 50-fold higher or lower expression as significant, which was further validated by real time RT-qPCR for 7 miRNAs (miR-34c-5p, miR-122, miR-146b-5p, miR-181a, miR-374b, miR-509 -5p, and miR513a-5p). The level of these 7 miRNAs was significantly lower in azoospermia and higher in asthenozoospermia compared to the control. Another noticeable finding of these authors was the stability of the above miRNAs to different conditions. They attributed this phenomenon to the small size of the miRNAs and their ability to bind with complex organic molecules in cellfree semen samples. Finally, they proposed that these 7 miRNAs might have confirmative molecular diagnostic value for male infertility.

In this regard, Wu et al. (44) evaluated the pattern of expression related to miR-I9b and let-7a in idiopathic infertile individuals with NOA or oligozoospermia by quantitative RT-PCR. They showed that these two miRNAs distinctively expressed at higher levels in infertile cases compared with fertile individuals. Consequently, they concluded that miR-I9b and let-7a were good diagnostic molecular biomarkers for idiopathic infertile cases with NOA or oligozoospermia.

Single nucleotide polymorphism (SNP) and function of miRNA in spermatogenesis

Considering the diverse role of miRNA in spermatogenesis, therefore any polymorphism in related genes might lead to infertility. Zhang et al. (45) were the first researchers who reported an association between miRNA-binding site single nucleotide polymorphism (SNP) and idiopathic male infertility. They systematically surveyed all SNPs in the 3' UTR of 140 mammal spermatogenesisrelated genes and observed that some SNPs within miRNA-binding sites might be related to idiopathic male infertility.

Among 140 surveyed genes, 6 SNPs (two in CYP19, Serpina5 and four in CGA, CPEB1, and CPEB2), involved in down regulation of gene expression in spermatogenesis and meiosis and were predicted to have possibility for altering the binding affinity of miRNA by using bioinformatically specialized algorithms (Pictar, miRanda, Targetscan, and RNAhybrid). The effectiveness of these SNPs in male infertility was analyzed in a case-control study using PCR followed by restriction digestion of the amplified fragments for genotyping. They realized that T substituted for A in rs6631 which lead to diminished binding ability of miR-1302 to its binding site in CGA in vitro, with a subsequent overexpression of CGA. Therefore an association between this special SNP and male infertility was concluded.

Recently Qin et al. (46) evaluated the relation between seven SNPs in the genes of Drosha (rs10719, rs2291109, rs17409893 and rs642321) and Dicer (rs13078, rs1057035 and rs12323635) and infertility. Performing genotyping by means of real time PCR, these researchers showed that SNPs in rs10719, rs12323635 and rs642321 were related with male infertility in the examined HanChinese population.

Conclusion and prospective

Considering limited number of studies performed in this field, little has been clarified about miRNA-mediated gene regulation in spermatogenesis. In addition, there are few numbers of published studies that focus on the role of miRNAs in male infertility. This review has aimed to elaborate the role of miRNA in the male reproductive system. Any disorder or failure in this system can result in male infertility. Therefore, a dysfunction in miRNA processing as with Dorsha and Dicer can result in azoospermia and infertility. Other anomalies such as dysregulation in expression of certain miRNAs or SNP in the miRNA binding site or SNP in the genes involved in biogenesis of miRNA can be related to infertility. Hence, in this regard, scientists suggest that assessment of miRNA may have future diagnostic value and shed more light on the molecular mechanisms of male infertility. Thus, new paths can be opened for future treatments of male infertility or even in the design of new contraceptive drugs.

Acknowledgements

There is no conflict of interest in this article.

References

References

1. Chen K, Rajewsky N. The evolution of gene regulation by transcription factors and microRNAs. Nat Rev Genet. 2007; 8(2): 93-103.

2. Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell. 2009; 136(2): 215-233.

3. Kusenda B, Mraz M, Mayer J, Pospisilova S. MicroRNA biogenesis, functionality and cancer relevance, Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2006; 150(2): 205-215.

4. Lee RC, Feinbaum RL, Ambros V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell. 1993; 75(5): 843-854.

5. Griffiths-Jones S, Grocock RJ, van Dongen S, Bateman A, Enright AJ. miRBase: microRNA sequences, targets and gene nomenclature. Nucleic Acids Res. 2006; 34 (Database issue): D140-D144.

6. Berezikov E, Cuppen E, Plasterk RH. Approaches to microRNA discovery. Nat Genet. 2006; 38 supple: S2-S7.

7. Landgraf P, Rusu M, Sewer A, Lovino N, Aravin A, Pfeffer S, et al. A mammalian microRNA expression atlas based on small RNA library sequencing. Cell. 2007; 129(7): 1401-1414.

8. Friedman RC, Farh KK, Burge CB, Bartel DP. Most mammalian mRNAs are conserved targets of microRNAs. Genome Res. 2009; 19(1): 92-105.

9. Le Bot N. miRNAs and cell-cycle control in ESCs. Nat Cell Biol. 2012; 14(7): 685.

10. Cheng AM, Byrom MW, Shelton J, Ford LP. Antisense inhibition of human miRNAs and indications for an involvement of miRNA in cell growth and apoptosis. Nucleic Acids Res. 2005; 33(4): 1290-1297.

11. Dennis LM. MicroRNAs in early embryonic development: dissecting the role of miR-290 through miR-295 in the mouse. Presented for the Ph.D., Cambridge. Massachusetts Institute of Technology. 2008 .

12. Latronico MV, Condorelli G. MicroRNAs and cardiac pathology. Nat Rev Cardiol. 2009; 6(6): 419-429.

13. Esquela-Kerscher A, Slack FJ. Oncomirs-microRNAs with a role in cancer. Nat Rev Cancer. 2006; 6(4): 259-269.

14. Hansen T, Olsen L, Lindow M, Jakobsen KD, Ullum H, Jonsson E, et al. Brain expressed microRNAs implicated in schizophrenia etiology. PLoS One. 2007 12; 2(9): e873.

15. Li JY, Yong TY, Michael MZ, Gleadle JM. Review: The role of microRNAs in kidney disease. Nephrology (Carlton). 2010; 15(6): 599-608.

16. Sonkoly E, Wei T, Janson PC, Sääf A, Lundeberg L, Tengvall-Linder M, et al. MicroRNAs: novel regulators involved in the pathogenesis of psoriasis?. PLoS One. 2007; 2(7): e610.

17. Eisenberg I, Eran A, Nishino I, Moggio M, Lamperti C, Amato AA, et al. Distinctive patterns of microRNA expression in primary muscular disorders. Proc Natl Acad Sci USA. 2007; 104(43): 17016-17021.

18. Kantharidis P, Wang B, Carew RM, Lan HY. Diabetes complications: the microRNA perspective. Diabetes. 2011; 60(7): 1832-1837.

19. Jangravi Z, Alikhani M, Arefnezhad B, Sharifi Tabar M, Taleahmad S, Karamzadeh R, et al. A fresh look at the malespecific region of the human Y chromosome. J Proteome Res. 2013; 12(1): 6-22.

20. Guzick DS, Overstreet JW, Factor-Litvak P, Brazil CK, Nakajima ST, Coutifaris C, et al. Sperm morphology, motility, and concentration in fertile and infertile men. N Engl J Med. 2001; 345: 1388-1393.

21. Barad O, Meiri E, Avniel A, Aharonov R, Barzilai A, Bentwich I, et al. MicroRNA expression detected by oligonucleotide microarrays: system establishment and expression profiling in human tissues. Genome Res. 2004; 14: 2486-2494.

22. Papaioannou MD, Nef S. microRNAs in the testis: building up male fertility. J Androl. 2010; 31(1): 26-33.

23. Yu Z, Raabe T, Hecht NB. MicroRNA Mirn122a reduces expression of the posttranscriptionally regulated germ cell transition protein 2 (Tnp2) messenger RNA (mRNA) by mRNA cleavage. Biol Reprod. 2005; 73(3): 427-433.

24. Kotaja N, Bhattacharyya SN, Jaskiewicz L, Kimmins S, Parvinen M, Filipowicz W, et al. The chromatoid body of male germ cells: similarity with processing bodies and presence of Dicer and microRNA pathway components. Proc Natl Acad Sci USA. 2006; 103(8): 2647-2652.

25. Novotny GW, Sonne SB, Nielsen JE, Jonstrup SP, Hansen MA, Skakkebaek NE, et al. Translational repression of E2F1 mRNA in carcinoma in situ and normal testis correlates with expression of the miR-17-92 cluster. Cell Death Differ. 2007; 14(4): 879-882.

26. Yan N, Lu Y, Sun H, Tao D, Zhang S, Liu W, et al. A microarray for microRNA profiling in mouse testis tissues. Reproduction. 2007; 134(1): 73-79.

27. Ro S, Park C, Sanders KM, McCarrey JR, Yan W. Cloning and expression profiling of testis-expressed microRNAs. Dev Biol. 2007; 311(2): 592-602.

28. Gonzalez-Gonzalez E, Lopez-Casas PP, del Mazo J. The expression patterns of genes involved in the RNAi pathways are tissuedependent and differ in the germ and somatic cells of mouse testis. Biochim Biophys Acta. 2008; 1779(5): 306-311.

29. Marcon E, Babak T, Chua G, Hughes T, Moens PB. miRNA and piRNA localization in the male mammalian meiotic nucleus. Chromosome Res. 2008; 16(2): 243-260.

30. Hayashi K, Chuva de Sousa Lopes SM, Kaneda M, Tang F, Hajkova P, Lao K, et al. MicroRNA biogenesis is required for mouse primordial germ cell development and spermatogenesis. PLoS One. 2008; 3(3): e1738.

31. Papaioannou MD, Pitetti JL, Ro S, Park C, Aubry F, Schaad O, et al. Sertoli cell Dicer is essential for spermatogenesis in mice. Dev Biol. 2009; 326(1): 250-259.

32. Wu Q, Song R, Ortogero N, Zheng H, Evanoff R, Small CL, et al. The RNase III enzyme DROSHA is essential for microRNA production and spermatogenesis. J Biol Chem. 2012; 287(30): 25173-25190.

33. McIver SC, Stanger SJ, Santarelli DM, Roman SD, Nixon B, McLaughlin EA. A unique combination of male germ cell miRNAs coordinates gonocyte differentiation. PLoS One. 2012; 7(4): e35553.

34. Kopreski MS, Benko FA, Kwak LW, Gocke CD. Detection of tumor messenger RNA in the serum of patients with malignant melanoma. Clin Cancer Res. 1999; 5(8): 1961-1965.

35. Li Y, Zhou X, St John MA,Wong DT. RNA profiling of cellfree saliva using microarray technology. J Dent Res. 2004; 83(3): 199-203.

36. Hanson EK, Lubenow H, Ballantyne J. Identification of forensically relevant body fluids using a panel of differentially expressed microRNAs. Anal Biochem. 2009; 387(2): 303-314.

37. Zhao H, Shen J, Medico L,Wang D, Ambrosone CB, Liu S. A pilot study of circulating miRNAs as potential biomarkers of early stage breast cancer. PLoS One. 2010; 5(10): e13735.

38. Aghajanpour S, Ghaedi K, Salamian A, Deemeh MR, Tavalaee M, Moshtaghian J, et al. Quantitative expression of phospholipase C zeta, as an index to assess fertilization potential of a semen sample. Hum Reprod. 2011; 26(11): 2950-2956.

39. Tseden K, Topaloglu O, Meinhardt A, Dev A, Adham I, Müller C, et al.Premature translation of transition protein 2 mRNA causes sperm abnormalities and male infertility. Mol Reprod Dev. 2007; 74(3): 273-279.

40. Motiei M, Tavalaee M, Rabiei F, Hajihosseini R, NasrEsfahani MH. Evaluation of HSPA2 in fertile and infertile individuals. Andrologia. 2013; 45(1): 66-72.

41. Yatsenko AN, Georgiadis AP, Murthy LJ, Lamb DJ, Matzuk MM. UBE2B mRNA alterations are associated with severe oligozoospermia in infertile men. Mol Hum Reprod. 2013; 19(6): 388-394.

42. Lian J, Zhang X, Tian H, Liang N, Wang Y, Liang Cet al. Altered microRNA expression in patients with non-obstructive azoospermia.Reprod Biol Endocrinol. 2009; 7: 13.

43. Wang C, Yang C, Chen X, Yao B, Yang C, Zhu C, et al. Altered profile of seminal plasma microRNAs in the molecular diagnosis of male infertility. Clin Chem. 2011; 57(12): 1722-1731.

44. Wu W, Hu Z, Qin Y, Dong J, Dai J, Lu C, et al. Seminal plasma microRNAs: potential biomarkers for spermatogenesis status. Mol Hum Reprod. 2012; 18(10): 489-497.

45. Zhang H, Liu Y, Su D, Yang Y, Bai G, Tao D, et al. A single nucleotide polymorphism in a miR-1302 binding site in CGA increases the risk of idiopathic male infertility. Fertil Steril. 2011; 96(1): 34-39.

46. Qin Y, Xia Y, Wu W, Han X, Lu C, Ji G, et al. Genetic variants in microRNA biogenesis pathway genes are associated with semen quality in a Han-Chinese population. Reprod Biomed Online. 2012; 24(4): 454-461.